Please assess the completion status of the following clinical trial:

Trial Title: Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Key Inclusion Criteria:~* Male or female between the ages of 12 and 40 (inclusive)~* Written and verbal informed consent must be obtained.~* Subjects less than 18 years of age must sign an assent for the study and a parent or a legal guardian must sign the informed consent~* Subject must have moderate to severe acne at the baseline visit~* Women of childbearing potential must be willing to practice effective contraception for the duration of the study~Key Exclusion Criteria:~* Use of an investigational drug or device within 30 days of enrollment or participation in a research study concurrent with this study~* Dermatological conditions on the face that could interfere with clinical evaluations

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- ACYC (Type: ACTIVE_COMPARATOR): ACYC active, topically applied to the face for 12 weeks
- ACYC vehicle (Type: PLACEBO_COMPARATOR): ACYC vehicle (placebo), topically applied to the face for 12 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).